Life Science Innovation Network Japan (LINK-J) launched the partnering event series “Advanced Therapy Showcase in Tokyo (ATST)” in January 2021. Following the two successful events, now we are pleased to announce that the third edition of the series, the ATST#3, is slated for Wednesday, February 1, 2023. Its format will be the same as its precedents, a virtual event featuring live-streaming company presentations and pre-arranged one-on-one business partnering meetings. The one-on-one meeting will be open on the five weekdays of the week.
Any entities or individuals engaged in the field of advanced therapy including but not limited to cell & gene therapy, regenerative medicine, nucleic acid medicine, etc. are encouraged to participate in this event to find suitable and relevant partner candidates for their business endeavors.
※This is the application site for general Attendees. Applications for the Live-Streaming Presenter on the day of the event will also be accepted until Friday, December 2.
For more information is click here
The detailed program can be found here
Date and Time:
Wednesday, February 1, 2023, JST 8:00～20:10
One-on-One Business Meetings: Monday, January 30 ~ Friday, February 3, 2023, JST
Venue:
Online
Registration
Registration (with questionnaire)
*Completion of the survey is free of charge for those who complete it.
Program
Official language：English
| Time | Program |
| 8:00 |
Opening Remarks by Hideyuki Okano, M.D., Ph.D. (Chairman of the Board, LINK-J) |
| 8:05- |
Live-streaming company presentation Participating companies |
| 11:45 |
Keynotes Tim HUNT, CEO (The Alliance for Regenerative Medicine (ARM) |
| 12:05- |
Break |
| 13:05- |
Live-streaming company presentation Participating companies |
| 17:15- |
Keynote Philippe Fauchet Owen Smith（4Bio Capital） |
| 17:35- |
Live-streaming company presentation Participating companies |
The detailed program can be found here
Live-Streaming Presenters
Mnemo Therapeutics SAS
Myogenica Inc.
Ocugen, Inc.
Progenicyte Japan Co., Ltd.
Ronawk, Inc.
RheumaGen, Inc.
Immusoft Corp.
ThinkCyte Inc.
Celaid Therapeutics Inc.
Delta-Fly Pharma, Inc.
iHeart Japan Corp.
iXgene Inc.
Luxna Biotech Co., Ltd.
Minaris Regenerative Medicine Co., Ltd.
PeptiGrowth Inc.
PuREC Corp.
Stempeutics Research Pvt. Ltd.
eTheRNA Immunotherapies NV
PDC*line pharma SA
EG 427
Eligo Biosicience SAS
SparingVision SAS
TreeFrog Therapeutics SAS
Salipro Biotech AB
Verigraft AB
Xintela AB
Orchard Therapeutics plc
Laverock Therapeutics Ltd.
Touchlight DNA Services Ltd.
Target
Product developers, novel technology providers, platform developers, and researchers who seek partners in Japan or elsewhere, and crave to excel in the field of advanced therapies such as;Any parties who are interested in partnering with product developers, novel technology providers, platform developers, and researchers who seek partners in Japan or elsewhere, and crave to excel in the field of advanced therapies such as;
- regenerative medicine and tissue engineering,
- cell therapy and gene-modified cell therapy,
- gene therapy (in vivo/ex vivo) and gene editing therapy,
- exosome based therapy,
- nucleic acid medicine,
- stem cell based drug discovery, etc.
Participation fee
10,000JPY /LINK-J non-member
5,000JPY / LINK-J member
Discount rate (7,500 JPY/organization) will be applied for those who present the discount code, which will be given to supporting organizations to distribute among its members
Registration deadline
TBD
Organizer
LINK-J
Event Supporters
 |
 |
 |
| American Chambers of Commerce in Japan (ACCJ) | Alliance for Regenerative Medicine(ARM) | BIOWIN |
 |
 |
 |
| Biocom | Centre for Commercialization of Regenerative Medicine(CCRM) | Cell & Gene Therapy Catapult |
 |
 |
 |
| Eurobiomed | FBRI | Forum for Innovative Regenerative Medicine (FIRM) |
 |
 |
 |
| 4BIO Capital | flanders.bio | Institute for Advanced Biosciences, Keio University |
 |
 |
 |
| Japan External Trade Organization （JETRO） | The Japanese Society for Regenerative Medicine | Kanagawa |
 |
 |
 |
| Kawasaki | Kyoto Research Park Corp. | Lyonbiopole |
 |
 |
 |
| MedCity | One Nucleus | Osaka |
 |
||
| Yokohama |
Contact
LINK-J
E-mail：atst@link-j.org
